Ritonavir HydroxyRitonavir EP IMP ERitonavir Impurity ERitonavir Hydroxy MetaboliteRitonavir IMpurity E (Hydroxy Ritonavir)Ritonavir EP Impurity E/ Hydroxy RitonavirRitonavir Impurity 5(Ritonavir EP Impurity E)Ritonavir Impurity E (Hydroxy Ritonavir) (M2)
DTXCID1092658Ritonavir EP Impurity EThiazol-5-ylmethyl ((2S,3S,5S)-3-hydroxy-5-((S)-2-(3-((2-(2-hydroxypropan-2-yl)thiazol-4-yl)methyl)-3-methylureido)-3-methylbutanamido)-1,6-diphenylhexan-2-yl)carbamateUNII-JN1D7K606NRitonavir specified impurity E [EP]starbld0024018Ritonavir impurity, hydroxyritonavir- [USP]RITONAVIR METABOLITE M2
Database identifiers
CAS
176655-56-4
PubChem CID
71749331
DTXSID
DTXSID10170167
ChEMBL
CHEMBL3544628
ChEBI
CHEBI:172813
UNII
JN1D7K606N
Nikkaji
J808.685K
Properties
Computed structural properties
XLogP
4.6
Topological polar surface area
222 Ų
Hydrogen bond donors
5
Hydrogen bond acceptors
10
Rotatable bonds
18
Heavy atoms
51
Formal charge
0
Complexity
1,090
Physicochemical properties
Melting point
76 · 76-80°C
storage temp.
-20 °C · -20°C Freezer
solubility
DMSO (Slightly), Ethyl Acetate (Slightly)
form
Solid
color
White to Pale Yellow
FDA UNII
1 D7K606N · JN1D7K606N
Chemistry & industry
Pharmacology
Tissue LocationsKidney
Cellular LocationsCytoplasm
Applications
UsesHydroxy Ritonavir (Ritonavir EP Impurity E) is a metabolite of Ritonavir (R535000), HIV-1 protease inhibitor. It is a COVID19-related research product.